Skip to content

In the BioHarmony Drug Report Database

Lamivudine

Epivir, Epivir-hbv, Zeffix (lamivudine) is a small molecule pharmaceutical. Lamivudine was first approved as Epivir on 1995-11-17. It is used to treat acquired immunodeficiency syndrome, hepatitis b, and HIV infections in the USA. It has been approved in Europe to treat chronic hepatitis b and HIV infections.
Trade Name Epivir, Zeffix
Common Name Lamivudine
Indication acquired immunodeficiency syndrome, chronic hepatitis b, hepatitis b, hiv infections
Drug Class Antineoplastics,antivirals (zidovudine group) (exception: edoxudine)
Lamivudine
Get full access now